Zhejiang Risun Intelligent Technology Co.,Ltd (SHA:688215)
China · Delayed Price · Currency is CNY 50.53
-0.53 (-1.04%)
Last updated: Aug 1, 2025
Verve Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 16.45 | 16 | 11.28 | 9.59 | 13.26 | 15.96 | Upgrade |
Depreciation & Amortization | 14.67 | 14.67 | 14.23 | 8.59 | 2.43 | 1.34 | Upgrade |
Other Amortization | 1.35 | 1.35 | 0.14 | 0.12 | 0.05 | 0.06 | Upgrade |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -0.07 | -0.02 | -0.13 | -0 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | -0.44 | 0.14 | 1.09 | Upgrade |
Provision & Write-off of Bad Debts | 5.86 | 5.86 | 9.29 | 12.71 | 5.69 | 6.5 | Upgrade |
Other Operating Activities | -6.61 | 5.55 | 8.26 | 3.48 | 0.46 | 2.19 | Upgrade |
Change in Accounts Receivable | -105.5 | -105.5 | -52.24 | -79.56 | -53.62 | -22.89 | Upgrade |
Change in Inventory | -18.02 | -18.02 | -22.6 | -56.54 | -49.61 | -1.79 | Upgrade |
Change in Accounts Payable | 55.74 | 55.74 | 11.22 | 56.37 | 80.73 | 2.36 | Upgrade |
Change in Other Net Operating Assets | -0.37 | -0.37 | -1.3 | 0.52 | -3.18 | 2.33 | Upgrade |
Operating Cash Flow | -36.6 | -24.89 | -23.23 | -48.08 | -5.42 | 6.44 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | -65.02% | Upgrade |
Capital Expenditures | -8.68 | -6.08 | -46.43 | -74.94 | -94.91 | -38.58 | Upgrade |
Sale of Property, Plant & Equipment | 0 | 0 | 0.05 | 0 | 0.97 | 0 | Upgrade |
Investment in Securities | -2 | -2 | -0.5 | 130 | -110 | -40 | Upgrade |
Other Investing Activities | - | - | 0.1 | 1.74 | 4.08 | 0.2 | Upgrade |
Investing Cash Flow | -10.68 | -8.08 | -46.78 | 56.81 | -199.86 | -78.39 | Upgrade |
Short-Term Debt Issued | - | - | - | 96.31 | 40.47 | 13 | Upgrade |
Long-Term Debt Issued | - | 151.47 | 84.6 | - | - | - | Upgrade |
Total Debt Issued | 164.39 | 151.47 | 84.6 | 96.31 | 40.47 | 13 | Upgrade |
Short-Term Debt Repaid | - | - | - | -78.75 | -13 | -13 | Upgrade |
Long-Term Debt Repaid | - | -109.98 | -41.91 | -1.15 | -1.47 | - | Upgrade |
Total Debt Repaid | -124.6 | -109.98 | -41.91 | -79.9 | -14.47 | -13 | Upgrade |
Net Debt Issued (Repaid) | 39.79 | 41.5 | 42.69 | 16.4 | 26.01 | - | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 347.65 | Upgrade |
Repurchase of Common Stock | -0.98 | -0.98 | - | - | - | - | Upgrade |
Common Dividends Paid | -7.74 | -7.47 | -6.39 | -7.67 | -6.87 | -0.68 | Upgrade |
Dividends Paid | -7.74 | -7.47 | -6.39 | -7.67 | -6.87 | -0.68 | Upgrade |
Other Financing Activities | -0.01 | 0.15 | 5.37 | 18 | - | -55.47 | Upgrade |
Financing Cash Flow | 31.06 | 33.2 | 41.68 | 26.74 | 19.14 | 291.5 | Upgrade |
Foreign Exchange Rate Adjustments | -0.26 | -0.25 | -0.94 | -0.12 | -0.57 | -1.46 | Upgrade |
Net Cash Flow | -16.48 | -0.02 | -29.27 | 35.33 | -186.71 | 218.1 | Upgrade |
Free Cash Flow | -45.28 | -30.97 | -69.65 | -123.03 | -100.33 | -32.14 | Upgrade |
Free Cash Flow Margin | -12.02% | -7.99% | -18.72% | -40.20% | -50.21% | -24.09% | Upgrade |
Free Cash Flow Per Share | -0.74 | -0.50 | -1.13 | -1.97 | -1.60 | -0.62 | Upgrade |
Cash Income Tax Paid | 15.94 | 19.43 | 16.14 | -2.87 | 2.31 | 11.36 | Upgrade |
Levered Free Cash Flow | -59.62 | -38.59 | -89.7 | -92.96 | -135.01 | -30.72 | Upgrade |
Unlevered Free Cash Flow | -57.52 | -36.67 | -88.69 | -91.87 | -134.27 | -30.3 | Upgrade |
Change in Net Working Capital | 75.56 | 56.21 | 67.21 | 30.34 | 42.69 | -5.11 | Upgrade |
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.